Burnt-Out Diabetes: Impact of Chronic Kidney Disease Progression on the Natural Course of Diabetes Mellitus

Journal of Renal Nutrition

Volumn 19, Issue 1, 2009, Pages 33-37

  Kalantar Zadeh, Kamyar ^a,b   Derose, Stephen F ^c   Nicholas, Susan ^b   Benner, Deborah ^d   Sharma, Kumar ^e   Kovesdy, Csaba P ^f  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Kaiser Permanente of Southern California ^*  (United States)

^d National Nutrition Division   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 58149099031     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.11.012     Document Type: Article

References (30)

1. Kovesdy C.P., and Sharma K. Kalantar-Zadeh K: Glycemic control in diabetic CKD patients: where do we stand?. Am J Kidney Dis 52 (2008) 766-777
2. United States Renal Data System: United States Renal Data System 2006 annual data report atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 49 (2007) 1-296
3. Gordois A., Scuffham P., Shearer A., and Oglesby A. The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complications 18 (2004) 18-26
4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
5. Matas A.J., Gillingham K.J., Humar A., et al. Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Transplantation 85 (2008) 338-343
6. Mak R.H. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial 13 (2000) 4-8
7. Akmal M., Massry S.G., Goldstein D.A., Fanti P., and Weisz A. DeFronzo RA: Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75 (1985) 1037-1044
8. Mak R.H., Bettinelli A., Turner C., Haycock G.B., and Chantler C. The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 60 (1985) 229-233
9. Cano N. Bench-to-bedside review: glucose production from the kidney. Crit Care 6 (2002) 317-321
10. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73 (2008) 391-398
11. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 18 (1989) 103-121
12. Schmitz O. Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects. Diabetes 34 (1985) 1152-1159
13. McCaleb M.L., Izzo M.S., and Lockwood D.H. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 75 (1985) 391-396
14. Heaton A., Taylor R., Johnston D.G., Ward M.K., Wilkinson R., and Alberti K.G. Hepatic and peripheral insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis. Clin Sci 77 (1989) 383-388
15. Sharma R., and Rosner M.H. Glucose in the dialysate: historical perspective and possible implications?. Hemodial Int 12 (2008) 221-226
16. Mak R.H. Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 40 (1996) 304-308
17. Mamoun A.H., Anderstam B., Sodersten P., Lindholm B., and Bergstrom J. Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats. Kidney Int 49 (1996) 1276-1282
18. von Baeyer H., Gahl G.M., Riedinger H., et al. Adaptation of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 23 (1983) 29-34
19. Skutches C.L., and Sigler M.H. Plasma glucose turnover and oxidation during hemodialysis: nutritional effect of dialysis fluid. Am J Clin Nutr 65 (1997) 128-135
20. Kopple J.D., Swendseid M.E., Shinaberger J.H., and Umezawa C.Y. The free and bound amino acids removed by hemodialysis. Trans Am Socr Artif Intern Organs 19 (1973) 309-313
21. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
22. Fluckiger R., Harmon W., Meier W., Loo S., and Gabbay K.H. Hemoglobin carbamylation in uremia. N Engl J Med 304 (1981) 823-827
23. Kalantar-Zadeh K., Mehrotra R., Fouque D., and Kopple J.D. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 17 (2004) 445-465
24. De Marchi S., Cecchin E., Camurri C., et al. Origin of glycosylated hemoglobin A1 in chronic renal failure. Int J Artif Organs 6 (1983) 77-82
25. Inaba M., Okuno S., Kumeda Y., et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18 (2007) 896-903
26. Kumeda Y., Inaba M., Shoji S., et al. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin Endocrinol (Oxf) 69 (2008) 556-561
27. Peacock T.P., Shihabi Z.K., Bleyer A.J., et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 73 (2008) 1062-1068
28. Morgan L.J., Marenah C.B., Morgan A.G., Burden R.P., and John W.G. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure. Nephrol Dial Transplant 5 (1990) 868-873
29. Kalantar-Zadeh K., Kopple J.D., Regidor D.L., et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 30 (2007) 1049-1055
30. Eshaghian S., Horwich T.B., and Fonarow G.C. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 151 (2006) 91